Medical cannabis firms press UK to loosen prescription rules

Not a member?

Continue with Google

Sign In

Academy

Articles

Ailments

Diagnoses

Cannvas Health Advocate Team (C.H.A.T.)

News

Posted June 25, 2019

Section: Regulatory

Related Ailments: Chronic Pain, Nauseous

The world’s largest medicinal cannabis company has urged the government to allow GPs to prescribe the drug, calling on the UK to be a “leader not a laggard” in one of the world’s fastest growing major industries.

Cam Battley, chief corporate officer of Canada-based Aurora Cannabis, said the UK was failing patients who might benefit from medicinal cannabis, as well as forfeiting economic gain, due to the restrictions of the existing regulatory regime.

Sajid Javid, the home secretary, authorized the use of medicinal products derived from cannabis last year following a long-running campaign fronted by the parents of children suffering from severe epilepsy, who reported that cannabis oil helped with their condition.

But it can only be prescribed by specialist physicians and cannot be imported until a prescription has been issued. These rules, coupled with division among doctors about how effective it is, means fewer than 100 patients are thought to have been prescribed it.

“What was the point of creating a medical cannabis system if patients can’t access it?” Battley said, speaking at the annual Cannabis Europa conference in London, attended by leading firms in the nascent but already multibillion dollar industry.

“It’s time for the UK to take this system that is not working and make it work,” he said. “Let’s make sure that general practitioners can prescribe. There’s no need for requiring a specialist consultant to write a prescription. I’d like to see the UK be a leader, not a laggard.”

David Henn, chief executive of Germany-based Cannamedical, backed Battley, saying the law “does not make great sense for patients” and also forced up costs.

He said restrictions on imports caused by the UK’s regulatory regime meant that Cannamedical could profitably sell medicinal cannabis to pharmacies in Germany at $10 (UK) a gram but would have to ask for $30 (UK) a gram to achieve the same margin in the UK.

“We need to be able to hold stock, bring in larger amounts so that as soon as there is a prescription you can distribute to pharmacies,” he said.

He added that a no-deal Brexit could make it near-impossible for UK patients to obtain medicinal cannabis, unless the UK aligns itself with EU rules on good manufacturing practice.

Campaigners and companies that produce cannabis say patients have reported that it can help with pain, epilepsy, and nausea, including sickness caused by chemotherapy.

Battley told The Guardian that the company was “making progress” in discussions with the government about loosening regulation, adding that it was only in the last year that politicians had been willing to speak to the company.

He pointed to Aurora’s domestic market of Canada, where he said the number of patients had gone from a handful to 400,000 in just a few years, with 20,000 physicians having prescribed cannabis since its medical use was legalized in 2001.

Recreational cannabis is also legal in Canada, which has become the de facto centre of the global industry, hosting giants such as Aurora, which produces 160,000kg of dried flower a year and has a stock market value of more than $5.5 billion (UK).

Source: https://www.theguardian.com/society/2019/jun/24/medical-cannabis-firms-press-uk-to-loosen-prescription-rules

This article is now marked as read.

Go back to Course

Back To Physician's Corner

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Rate & Review

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Access to cannabis for medical reasons is now allowed in Ireland under new law

Health Minister Simon Harris has today signed legislation to allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years.

Cyprus legalizes medical cannabis

The House of Representatives in Cyprus have passed a law regulating the production, use and import of medicinal cannabis.

Medical cannabis could be purchased for more conditions under Iowa Senate Bill

A Senate subcommittee approved a bill early this week that would allow patients to access medical cannabis for a wider range of health problems than previously depicted.

Minnesota Expands Medical Marijuana Qualifications

The addition of two new conditions that qualify for medical marijuana in Minnesota have gone into effect as of July 1st, after being approved by the Minnesota Department of Health in November.

Portugal Officially Legalizes Cannabis-Based Medicines

A bill to legalize cannabis-based medicines that was approved last month by the Portuguese Parliament officially went into law July 1.

Utah Lawmakers Will Implement Medical Marijuana Bill Regardless of Voter Consensus

On November 2 Utah voters will see Proposition 2 on the ballot, but regardless of how they vote, Utah lawmakers say they will pass a bill on medical marijuana post election.

4/20 Event in Ottawa Features 14 Year Old as Keynote Speaker

At the age of 11, Emma Boniface watched her mother lose herself in the grasp of an opioid addiction.

Could mood specific cannabis strains be the next big thing?

Many people who use cannabis and CBD for well-being or to deal with their medical issues prefer different delivery systems and even different cannabis strains depending on the specific effects and mood they want to feel.

Missouri cannabis clinic to offer free evaluations to veterans in July

A Missouri medical cannabis clinic with three locations set to open in July will offer free evaluations to veterans for the first 30 days, Ozarks First reports.

Queensland's First Cannabis Clinic Opens

After opening offices in Sydney and Melbourne, Cannabis Access Clinics has opened Queensland’s first cannabis clinic in the Brisbane suburb of Belmont.

Retailers struggle to keep popular cannabis extract CBD on shelves in Canada

Retailers across Canada are struggling with a shortage of all cannabis, but there’s one product they’re especially desperate to keep on shelves: cannabidiol or CBD, a non-intoxicating extract praised for its purported health benefits.

The New Grey Market: As Older Users Warm Up To Cannabis, Companies Want To Learn More

In early October, Canopy Growth Corporation announced a six-month study tracking and monitoring the effects of medical cannabis as an alternative to other forms of pain management. Canopy partnered with the Ontario Long Term Care Association for the...

3 Ways CBD Oil Has Changed the Way We View Cannabis

Cannabidiol, or CBD, has recently peaked in popularity in the world of holistic medicine, but what do people really know about this seemingly miraculous plant? While there are many misconceptions about cannabis and CBD oil, it’s safe to say the two h...

A Growing Number of People Are Trading Their Pain Meds for Cannabis, Study Finds

As more states legalize cannabis, a new study has found many patients are choosing medical cannabis to supplement and even replace pharmaceutical drugs.

B.C. Cancer to lead first national cannabis clinical trial for symptom relief

B.C. Cancer will lead a first-ever national clinical trial to determine whether cannabis plant extracts truly help with symptom relief. The trial will examine how cannabis properties affect and possibly reduce cancer-related symptoms including pain,...

Cannabis and Mental Health: Postpartum Depression

"You live nine months with this little person inside of you. You go everywhere together. You’re never alone. The little person starts to move and hiccup and kick you. You know this little person. He is part of you," explains a mother who asked not to...

Cannabis Could Be Possible Treatment For Inflammatory Bowel Disease and Ulcertative Colitis

Speaking at Digestive Disease Week in Washington, two doctors, one from Toronto’s Mount Sinai hospital, and the other from Meir General hospital in Israel, gave separate presentations on cannabis treatments for inflammatory bowel disease (IBD) and ul...

Cannabis offers promise as a treatment for endometriosis pain and other symptoms

Almost 180 million women around the world suffer from endometriosis, and those who use cannabis to help treat the painful related symptoms rave about the relief they feel. Not only do experts cite anecdotal reports from women of less physical discomf...

Cannabis Study of Expecting Mothers Causes Social Media Controversy

A new study taking place at the University of Washington School of Medicine entitled, Moms + Marijuana seeks area participants to examine the effects of “prenatal cannabis use on infant development.” The study aims to determine whether or not using c...